- Home
- NAT vs YDES Comparison
NAT vs YDES Comparison
Compare NAT & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAT | YDES |
|---|---|---|
| Founded | 1995 | 2013 |
| Country | Bermuda | Taiwan |
| Employees | N/A | N/A |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 914.8M | 894.2M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | NAT | YDES |
|---|---|---|
| Price | $4.90 | $8.55 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.25 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 24.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 7.04% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24.97 | N/A |
| P/E Ratio | $525.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.13 | $7.90 |
| 52 Week High | $4.93 | $25.00 |
Technical Indicators
Market Signals| Indicator | NAT | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 83.59 | 33.29 |
| Support Level | $4.46 | $8.40 |
| Resistance Level | $4.25 | $11.80 |
| Average True Range (ATR) | 0.13 | 0.76 |
| MACD | 0.04 | -0.25 |
| Stochastic Oscillator | 96.61 | 15.83 |
Price Performance
Historical ComparisonAbout NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.